/
HAE
$90.38-$0.96 (-1.05%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$4.2B
45M shares
52-week range
$47.32 – $92.25
96% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NYSE
CS
Change+$31.60
Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
www.haemonetics.com- Employees
- 3,009
- IPO / List date
- May 9, 1991
- HQ
- BOSTON, MA
Held by traders on TradeandTell
No one on the platform currently holds HAE.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2026-03-31 | 48,377 | $2.7M |
| Renaissance Technologiesas of 2026-03-31 | 43,200 | $2.4M |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2012-12-03 | 2-for-1 |
Recent trades on TradeandTell
No one on the platform has traded HAE yet.
